Literature DB >> 28375710

High Interleukin-10 Expression in Type 2 T Helper Cells in Septic Patients.

Huang-Pin Wu1,2, Chien-Ming Chu1, Kuo-Chin Kao2,3, Shu-Huan Huang4, Duen-Yau Chuang5.   

Abstract

Interleukin (IL)-10 response is associated with mortality in patients with sepsis. IL-10 is primarily produced by monocytes and type 2 T helper (Th2) cells. The aim of this study was to investigate differences in IL-10 production between monocytes and Th2 cells in patients with sepsis. Forty patients with sepsis and 35 healthy controls were enrolled. Cytokine expressions in peripheral blood mononuclear cells (PBMCs) were measured by flow cytometry. The IL-10 expression in the Th2 cells of the septic patients was higher than in the healthy controls, but the expression of IL-10 in the monocytes of the septic patients was lower than in the healthy controls. After regression analysis, IL-10 expression in Th2 cells was positively associated with sepsis, but IL-10 expression in monocytes was not associated with sepsis or shock. In conclusion, the production of IL-10 in Th2 cells was higher in the patients with sepsis.

Entities:  

Keywords:  Interleukin-10; monocytes; sepsis; type 2 T helper cells

Mesh:

Substances:

Year:  2017        PMID: 28375710     DOI: 10.1080/08820139.2017.1288237

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  2 in total

1.  Effect of IL-10 in the pathogenesis of HIV/AIDS patients with cryptococcal meningitis.

Authors:  Lida Mo; Guosheng Su; Hanzhen Su; Wanhong Huang; Xiaolu Luo; Chuanmin Tao
Journal:  Mol Cell Biochem       Date:  2022-06-16       Impact factor: 3.396

2.  Circulating CD14+HLA-DR-/low Myeloid-Derived Suppressor Cells as Potential Biomarkers for the Identification of Psoriasis TCM Blood-Heat Syndrome and Blood-Stasis Syndrome.

Authors:  Shipeng Sun; Yali Wei; Xue Zeng; Yuliang Yuan; Na Wang; Cheng An; Jinlong Duan; Bo Pang; Zifu Hong; Guijian Liu
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-14       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.